Vertically integrated producer of a portfolio of diverse chemical products based on the calcium carbide / calcium cyanamide chain with strategic focus on growth of its Specialty Chemicals segment
Leading market positions in selected niche markets
R&D focus on developing products supported by megatrends
Integrated manufacturing system (“Verbund System”) allows for flexible dealing with changes of demand in diversified end markets
Headquartered in Germany, global sales and distribution network
Four production facilities in Germany, one in Sweden
Ulli Seibel, CEO
Ulli Seibel was born in 1975 in Landau in der Pfalz. He has studied industrial engineering (Wirtschaftsingenieurwesen) in Karlsruhe. After his studies he started his career as assistant of the management board of Fundatio AG. Between 2005 and 2009, he worked at Arques Industries AG, most recently as Vice President Operations. From 2009 until 2011 he was managing director of AlzChem Trostberg GmbH. Following the transformation of the Company into a stock corporation in 2011, he has been appointed as member of the Management Board of the AlzChem AG. Since Oktober 2017 he has been Chairman of the Management Board of AlzChem Group AG.
Andreas Niedermaier, CFO
Andreas Niedermaier was born in 1969 in Tittmoning. He has studied industrial engineering (Wirtschaftsingenieurwesen) in Rosenheim. After his studies he started his career as a consultant in cost accounting and controlling at Kettner Maschinenbau GmbH. From 1997 until 1999 he was a controller at Vinnolit GmbH & Co. KG at Gendorf and Burghausen where he was responsible for the production site controlling. Andreas Niedermaier has been with AlzChem since 1999. From 2010 until 2011 he was managing director of AlzChem Trostberg GmbH. Following the transformation of AlzChem into a stock corporation in 2011, he has been appointed as member of the Management Board of the Company. Since Oktober he is CFO of AlzChem Group AG.
Klaus Dieter Englmaier, COO
Klaus Dieter Englmaier was born in 1960 in Trostberg. He has studied mechanical engineering (Maschinenbau) in Munich. After his studies he started his career in the plant engineering department at Wacker Chemie GmbH in Burghausen in 1985. Klaus Dieter Englmaier is with AlzChem since 1988 when he joint AlzChem as a plant manager for the calcium cyanamide production. . In 2006 he was given overall responsibility for production and engineering at the finishing chemicals unit of AlzChem. From 2010 until 2016 he was a site manager for the chemical parks Trostberg and Hart. Since 2016 he has been a member of the Management Board of AlzChem AG. Since Oktober 2017 he has been appointed as a Member of the Management Board of AlzChem Group AG.
Markus Zöllner (Chairman)
Markus Zöllner was born in Straubing in 1968. He has studied industrial engineering (FH) (Wirtschaftsingenieurwesen) in Rosenheim. After his studies he started his career as engineer in 1993 at the Mannesmann Mobilfunk GmbH. In 2000 he obtained a MBA degree (WHU-Kellogg). In 2002 he was appointed as managing director (Geschäftsführer) of Tesion Telekommunikation GmbH. In 2003 he was appointed as managing director at Versatel Deutschland GmbH where he acted as CFO. From 2005 until 2007. Markus Zöllner was a member of the management board (Vorstand) of Arques Industries AG. Since 2009 he is chairman of the Supervisory Board of AlzChem AG and since 2017 at AlzChem Group AG. Markus Zöllner is also chairman of the board of directors (Verwaltungsrat) of KA Home Furnishing Oy, Finland, and Antilla Oy, Finland, and currently working as partner at 4K Invest and acting as managing director (Geschäftsführer) for his own investment company, four two na GmbH.
During the last five years Zöllner was also member of the supervisory board of Antilla AS, Estonia, SIA Antti, Latvia, and Adria Airways d.d., Slovenia.
Prof. Dr. Martina Heigl-Murauer
Prof. Dr. Martina Heigl-Murauer was born in 1967 in Deggendorf. She has studied business administration (Betriebswirtschaftslehre) in Rosenheim until 1994. After her studies she started her career as an associate at the Steuerberater- und Wirtschaftsprüfunggesellschaft Dr. Kittl & Partner and became a tax consultant. Following her PhD studies in international tax law from 2005 until 2009 in Bratislava Prof. Dr. Martina Heigl-Murauer was appointed professor at the University of Applied Sciences in Deggendorf. In 2012 she became member of the senate of the University of Applied Sciences in Deggendorf and since 2013 she is chairwoman of this senate. Until 2015 she worked as a self-employed tax consultant in Landshut. Since 2015 Prof. Dr. Martina Heigl-Murauer is working as a tax consultant for Ecovis BLB Steuerberatungsgesellschaft. Since 2016 she is member of the Supervisory Board at AlzChem AG and since 2017 at AlzChem Group AG.
Dr. Caspar Freiherr von Schnurbein
Dr. Caspar Frhr. v. Schnurbein was born in 1973 in Augsburg. He has studied law at the universities of Würzburg, Coimbra (Portugal) and Munich, where he passed his first and second legal state exam. Following his PhD studies in stock corporation law he started his career as corporate and M&A lawyer in the Munich office of an international law firm. Dr. Caspar Frhr. v. Schnurbein is currently working as general counsel of LIVIA Corporate Development SE where he is responsible for all legal matters. Since 2016 he is member of the Supervisory Board at AlzChem AG and since 2017 at AlzChem Group AG. He is also chairman of the supervisory board of LIVIA Emerging Markets AG, LIVIA Organic Industries AG and TUBIS AG.
During the last five years, Dr. Caspar Frhr. v. Schnurbein was also member of the supervisory board of LIVIA Corporate Development SE.
Steve Röper was born in 1976 in Waren (Müritz). He has studied law at the University of Rostock and passed his second legal state exam in Munich. From 2004 to 2007 he worked as an attorney at Heussen Rechtsanwaltsgesellschaft in Munich, as part of the corporate and commercial law team. From 2007 to 2009 he worked for KraussMaffei Group, Munich, where he served as senior counsel for the extrusion division. In 2009 he joined the Luxembourg-based private equity fund bluO as general counsel. Since 2013, he is a self-employed attorney in Munich. In 2009, he became member of the Supervisory Board at AlzChem AG. Effective October 2017, he was appointed to the Supervisory Board of AlzChem Group AG. He is also member of the board of directors of Anttila Oy, Finland.
|Net sales (EUR m)||294.4||290.7||322.6||327.2|
|EBITDA (EUR m)||33.6||32.4||33.2||38.6|
|Adjusted EBITDA (EUR m)*||-||-||-||44.9|
|Adjusted EBITDA margin*||-||-||-||13.7%|
|CF from operating activities (EUR m)||15.6||17.9||28.2||33.1|
* Prior to non-operating one-off effects in the course of the planned IPO in the amount of EUR 6.3m